A detailed history of Navellier & Associates Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Navellier & Associates Inc holds 42,779 shares of BSX stock, worth $4.39 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
42,779
Previous 47,593 10.11%
Holding current value
$4.39 Million
Previous $5.11 Million 18.29%
% of portfolio
0.46%
Previous 0.68%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

SELL
$97.03 - $108.14 $467,102 - $520,585
-4,814 Reduced 10.11%
42,779 $4.18 Million
Q2 2025

Aug 07, 2025

SELL
$89.7 - $107.41 $1.84 Million - $2.2 Million
-20,519 Reduced 30.13%
47,593 $5.11 Million
Q1 2025

May 06, 2025

BUY
$89.38 - $106.18 $5.64 Million - $6.7 Million
63,142 Added 1270.46%
68,112 $6.87 Million
Q1 2024

May 13, 2024

BUY
$57.6 - $68.62 $14,400 - $17,155
250 Added 5.3%
4,970 $340,000
Q4 2023

Feb 08, 2024

BUY
$48.64 - $57.81 $229,580 - $272,863
4,720 New
4,720 $272,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Navellier & Associates Inc Portfolio

Follow Navellier & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Navellier & Associates Inc with notifications on news.